Randomized clinical trial comparing a titanium-nitride-oxide coated stent with a Zotarolimus-eluting stent in patients with coronary artery disease.

Trial Profile

Randomized clinical trial comparing a titanium-nitride-oxide coated stent with a Zotarolimus-eluting stent in patients with coronary artery disease.

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Apr 2014

At a glance

  • Drugs Zotarolimus (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Apr 2012 Actual patient number is 302 according to ClinicalTrials.gov.
    • 05 Apr 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
    • 05 Apr 2012 Planned end date changed from 1 Jun 2012 to 1 Sep 2013 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top